Paymentus Holdings, Inc.
PAY NYSE Services-Business Services, Nec Financials FY2019βFY2025
What Paymentus Holdings, Inc. does
No business description yet.
- Legal name
- Paymentus Holdings, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001193125-26-064510
0001841156
Revenue and margins
Paymentus Holdings, Inc. had $1.2B of revenue in fiscal 2025, up 37.3% on the year before.
Net income and earnings per share
From fiscal 2019 to 2025, diluted EPS grew 36.6% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $162M in fiscal 2025, 13.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Paymentus Holdings, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 1.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Paymentus Holdings, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $168M | $147M | $179M | $206M | $321M |
| Current ratio | 3.4x | 4.4x | 4.3x | 4.2x | 4.5x |
| Quick ratio | 3.4x | 4.4x | 4.3x | 4.2x | 4.5x |
| Total assets | $473M | $462M | $505M | $576M | $668M |
| Total liabilities | $86.8M | $64.4M | $75.2M | $90.7M | $107M |
| Shareholders' equity | $386M | $397M | $430M | $486M | $560M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 5 | 4 / 8 | 4 / 8 | 5 / 8 | 5 / 8 | 6 / 8 |
| Accruals ratio | β | β17.5% | β3.4% | β4.4% | β9.6% | β3.6% | β15.3% |
| Altman Z'' | β | 7.18 | 7.55 | 9.17 | 9.27 | 9.70 | 10.39 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $236M | $302M | $396M | $497M | $614M | $872M | $1.2B |
| Provision for credit losses | β | $0.1M | $0.1M | $0.3M | $0.3M | β | β |
| Gross profit | $74.4M | $92.6M | $121M | $150M | $182M | $238M | $296M |
| Research and development | $17.9M | $24.5M | $34.1M | $41.2M | $44.2M | $51.3M | $61.5M |
| Operating income | $18.4M | $18.4M | $10.4M | β$3.0M | $18.1M | $44.9M | $75.5M |
| Pretax income | $18.5M | $18.4M | $10.4M | β$1.3M | $25.1M | $53.9M | $85.3M |
| Income tax | $4.8M | $4.7M | $1.1M | β$0.8M | $2.8M | $9.8M | $18.3M |
| Net income | $13.7M | $13.7M | $9.3M | β$0.5M | $22.3M | $44.2M | $66.9M |
| Net income to common | $9.0M | $8.5M | $7.0M | β$0.5M | $22.3M | β | β |
| Diluted EPS | $0.08 | $0.08 | $0.06 | $0.00 | $0.18 | $0.35 | $0.52 |
| Diluted shares | 0.11B | 0.11B | 0.12B | 0.12B | 0.13B | 0.13B | 0.13B |
| Cash flow | |||||||
| Cash from operations | $17.5M | $35.6M | $19.5M | $19.9M | $68.8M | $63.6M | $162M |
| Capital expenditure | $1.0M | $0.5M | $1.0M | $1.3M | $0.6M | $0.5M | $0.4M |
| Free cash flow | $16.5M | $35.2M | $18.5M | $18.6M | $68.2M | $63.2M | $162M |
| Depreciation and amortization | $6.0M | $8.1M | $13.3M | $24.1M | $30.6M | $36.5M | $41.1M |
| Stock-based compensation | $1.6M | $2.0M | $3.1M | $6.7M | $9.4M | $11.0M | $18.6M |
| Acquisitions | $1.4M | β$0.3M | $57.4M | $3.3M | $0.0M | $0.0M | β |
| Balance sheet | |||||||
| Cash and short-term investments | $27.4M | $46.7M | $168M | $147M | $179M | $206M | $321M |
| Finance lease liabilities | β | β | $0.4M | $0.1M | β | β | β |
| Current assets | β | $79.8M | $256M | $229M | $270M | $346M | $441M |
| Current liabilities | β | $31.1M | $74.4M | $51.5M | $62.8M | $81.6M | $98.8M |
| Property and equipment, net | β | $1.8M | $2.0M | $1.8M | $1.6M | $1.2M | $0.9M |
| Goodwill | $13.2M | $13.2M | $129M | $132M | $132M | $132M | $132M |
| Intangible assets | β | $0.3M | $42.1M | $36.0M | $27.2M | $19.1M | $12.0M |
| Total assets | β | $125M | $473M | $462M | $505M | $576M | $668M |
| Total liabilities | β | $40.5M | $86.8M | $64.4M | $75.2M | $90.7M | $107M |
| Preferred stock | β | $0.0M | $0.0M | $0.0M | $0.0M | β | β |
| Shareholders' equity | $68.6M | $84.4M | $386M | $397M | $430M | $486M | $560M |
| Margins | |||||||
| Gross margin | 31.6% | 30.7% | 30.7% | 30.1% | 29.7% | 27.3% | 24.8% |
| Operating margin | 7.8% | 6.1% | 2.6% | β0.6% | 2.9% | 5.1% | 6.3% |
| EBITDA margin | 10.3% | 8.8% | 6.0% | 4.2% | 7.9% | 9.3% | 9.7% |
| Net margin | 5.8% | 4.5% | 2.4% | β0.1% | 3.6% | 5.1% | 5.6% |
| FCF margin | 7.0% | 11.7% | 4.7% | 3.7% | 11.1% | 7.2% | 13.5% |
| Returns | |||||||
| Return on capital employed | β | 19.7% | 2.6% | β0.7% | 4.1% | 9.1% | 13.3% |
| Return on equity | 20.0% | 17.9% | 4.0% | β0.1% | 5.4% | 9.7% | 12.8% |
| Return on assets | β | 11.0% | 3.1% | β0.1% | 4.6% | 8.2% | 10.8% |
| Return on tangible equity | 16.3% | 12.0% | 3.3% | β0.2% | 8.2% | 13.2% | 16.1% |
| Growth | |||||||
| Revenue growth | β | 28.0% | 31.1% | 25.7% | 23.6% | 41.9% | 37.3% |
| Net income growth | β | 0.1% | β32.2% | β105.5% | β | 97.9% | 51.5% |
| EPS growth | β | 0.0% | β25.0% | β100.0% | β | 94.4% | 48.6% |
| FCF growth | β | 113.5% | β47.3% | 0.5% | 266.6% | β7.4% | 156.1% |
| Share count change | β | β0.1% | 11.9% | 2.8% | 2.4% | 2.1% | 1.1% |
| Financial health | |||||||
| Current ratio | β | 2.6x | 3.4x | 4.4x | 4.3x | 4.2x | 4.5x |
| Quick ratio | β | 2.6x | 3.4x | 4.4x | 4.3x | 4.2x | 4.5x |
| Capital allocation | |||||||
| Capex / revenue | 0.4% | 0.2% | 0.2% | 0.3% | 0.1% | 0.1% | 0.0% |
| Stock comp / revenue | 0.7% | 0.7% | 0.8% | 1.4% | 1.5% | 1.3% | 1.6% |
| Quality scores | |||||||
| Piotroski F-score | β | β | 4.0 | 4.0 | 5.0 | 5.0 | 6.0 |
| Altman Z'' | β | 7.2 | 7.5 | 9.2 | 9.3 | 9.7 | 10.4 |
| Accruals ratio | β | β17.5% | β3.4% | β4.4% | β9.6% | β3.6% | β15.3% |
Source: SEC EDGAR XBRL filings (CIK 0001841156). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.